Pharmafile Logo
Pharmafocus logo
Advanced Search
facilities_lg06

13 FDA observations on Dr Reddy’s plant send shares to 3 year low

March 9, 2017
Manufacturing and Production Dr Reddy's, FDA

Indian pharmaceutical firm Dr Reddy’s has seen its shares drop on the Bombay Stock Exchange to their lowest point in …

News
charity_gifts_for_children_with_cancer_foundation_vanessa_isabel

Looming Brexit sparks fears for child cancer trials, experts warn

March 9, 2017
Medical Communications, Research and Development EU, ICR, brexit

The trials of cancer treatments in the EU are already at a low level and Brexit has experts worried that …

News
park-profile-trans

Keapstone Therapeutics created out of Sheffield Uni and Parkinson’s UK link

March 8, 2017
Research and Development Keapstone therapeutics, Parkinson's UK, University of Sheffield

The University of Sheffield and Parkinson’s UK has created, in a first-of-a-kind, a virtual biotech company for developing therapies against …

News
acute_leukemia-all

New drug combination gives hope for acute myeloid leukaemia treatment

March 8, 2017
Research and Development acute myeloid leukaemia

A new trial in the US hopes to marry a new pair of drugs as a combination treatment for acute …

News
trevor-philips

Vectura’s COO set to step down

March 8, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing vectura

Vectura’s Chief Operating Officer, Trevor Phillips, will step down from the board on 25 May before leaving the company on …

Appointment
amgen_hq

FDA and NICE approve of first new hyperparathyroidism drug in 12 years

March 8, 2017
Research and Development, Sales and Marketing FDA, NICE, Parsabiv, hyperparathyroidism

The FDA has given the go-ahead for Amgen’s hyperparathyroidism (HPT) therapy Parsabiv (etelcalcetide), marking the first new treatment for patients …

News
web_scientist-filling-out-form---credit-national-institutes-of-health

Diabetes drug could be key to treating aggressive breast cancer, research suggests

March 8, 2017
Research and Development Cancer, diabetes

Researchers from the Zhejiang University School of Medicine have identified that the function of metabolic enzyme AKR1B1 is key to …

News
child

Research gives hope of potential treatment for most deadly paediatric brain tumour

March 8, 2017
Research and Development

A study conducted by researchers from Northwestern Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago has given …

News
gdd_logo_002

BeiGene to develop $330 million biologics plant

March 7, 2017
Manufacturing and Production, Research and Development BeiGene, China, Guangzhou

BeiGene, a Chinese biotech company, and Guangzhou GET Technology Development, an affiliate of Guangzhou Development District, will partner in the …

News
shutterstock_38078521

Researchers discover worrying new antibiotic-resistance gene variant

March 7, 2017
Manufacturing and Production, Research and Development drug resistance

A new variant of a human gene which is known to cause significant drug resistance in patients has been discovered …

News
shutterstock_92671375

Cadila and Supernus settle patent dispute over epilepsy generic

March 7, 2017
Manufacturing and Production, Sales and Marketing Cadila, Supernus, Trokendi XR, Zydus Cadila

A patent dispute between Indian pharmaceutical firm Cadila Healthcare and US-based Supernus Pharmaceuticals has been ended with legal calls for …

News

Merck’s Allergopharma opens €42m biopharmaceutical plant

March 7, 2017
Manufacturing and Production Allergopharma, Merck

Allergopharma, a subsidiary of Germany’s Merck, has completed construction on its new €42 million biopharmaceutical facility and declared it open …

News
bernie_2

Vermont senators call for restraints on “beautiful” pharma advertising

March 6, 2017
Manufacturing and Production, Sales and Marketing Bernie Sanders, Vermont, pricing

Bernie Sanders is yet again leading the charge against US pharma as Vermont senators have rallied against advertising and marketing …

News
sink

FDA approves first treatment for excessive night-time urination

March 6, 2017
Manufacturing and Production FDA, Noctiva, Serenity

The FDA has approved Noctiva, administered as a nasal spray, for the treatment of people suffering from nocturnal polyuria – …

News
europe_tied_in_knots

Negotiating the EU pricing system: How the financial crisis has encouraged closer-knit cooperation between member states

March 6, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, pricing

Drug pricing is a topic that has become headline-friendly over the past year. It has come to dominate media coverage …

Feature

Lilly posts impressive psoriasis results in comparison study

March 6, 2017
Research and Development, Sales and Marketing J&J, JJ, Stelara, Taltz, lilly

Eli Lilly has revealed strong results in a study comparing its psoriasis treatment, Taltz (ixekizumab), to Johnson & Johnson’s Stelara. …

News
mediaphoto7_large

Cipla halts HIV drug production due to delayed government funding

March 6, 2017
Sales and Marketing Cipla, HIV, India, Lopinavir

Indian pharmaceutical company Cipla has halted production of its child-friendly antiretroviral HIV treatment Lopinavir (ABT-378) due to the failure by …

News
abbvie_0

UK High Court rules against AbbVie’s Humira patents

March 6, 2017
Sales and Marketing AbbVie, Biogen, Fujifilm Kyowa Kirin Biologics, Humira, Samsung Bioepis, biosimilar

The UK High Court has ruled that two of AbbVie patents, related to dosing regimens for rheumatoid arthritis, psoriasis and …

News
janssen_latest_logo_on_sign_closer

Phase 3 data for Janssen psoriasis drug shows efficacy over Humira

March 6, 2017
Research and Development, Sales and Marketing Humira, Janssen, guselkumab, psoriasis

Janssen has revealed new Phase 3 data for its human monoclonal antibody guselkumab in the treatment of adults with moderate …

News
otsuka_holdings_logo

Otsuka to acquire Neurovance in potential $250 million deal

March 6, 2017
Sales and Marketing ADHD, Neurovance, Otsuka Pharmaceuticals

Otsuka Pharmaceuticals, a pharmaceutical firm with headquarters in Japan, has agreed to pay a potential $250 million in a deal …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026